lobbying_activities: 2776029

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2776029	28cbeef6-57ba-434a-971a-9a881d6041bb	Q1	FORBES-TATE	400976792	AMGEN USA, INC.	2022	first_quarter	MED	Issues related to Biosimilars.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2022-04-15T18:27:50-04:00